Burstein Jennifer 4
4 · Stoke Therapeutics, Inc. · Filed Jun 4, 2025
Insider Transaction Report
Form 4
Burstein Jennifer
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2025-06-03+29,747→ 29,747 totalExercise: $10.90Exp: 2035-06-02→ Common Stock (29,747 underlying)
Footnotes (1)
- [F1]The option shall vest in full on the earlier of: (i) June 3, 2026 or (ii) the date of the issuer's next annual meeting of its stockholders, subject to the reporting person's continued service to the issuer on the vesting date.